AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Autonomix Medical, Inc. Common Stock
XNAS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG00R28GXX4
2.42▼ 0.08 (-3.20%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
2.50
Day's Range
2.42 – 2.50
52-Week Range
0.20 – 24.68
Volume
59.8K
Avg Volume
161.8K
Share Statistics
Shares Outstanding
Employees
11
Exchange
XNAS
Listed
2024-01-29
Share count as of August 6, 2026

Autonomix Medical, Inc. Common Stock (AMIX) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Autonomix Medical, Inc. Common Stock (AMIX)
What is Autonomix Medical, Inc. Common Stock's Market Cap?
Autonomix Medical, Inc. Common Stock's Market Cap is $2.3M, based on as-reported figures from SEC (XBRL) filings.
What is Autonomix Medical, Inc. Common Stock's Revenue (TTM)?
Autonomix Medical, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Autonomix Medical, Inc. Common Stock's Net Income (TTM)?
Autonomix Medical, Inc. Common Stock's Net Income (TTM) is -$16.1M, based on as-reported figures from SEC (XBRL) filings.
What is Autonomix Medical, Inc. Common Stock's EBITDA?
Autonomix Medical, Inc. Common Stock's EBITDA is -$16.4M, based on as-reported figures from SEC (XBRL) filings.
What is Autonomix Medical, Inc. Common Stock's Diluted EPS (TTM)?
Autonomix Medical, Inc. Common Stock's Diluted EPS (TTM) is -16.59, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · AMIXAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income:
Interest income
Total other income
Loss before income taxes
Income taxes
Net loss
Loss per share - basic and diluted (in dollars per share)